Metal–organic framework nanovaccines for systemic tumour regression
6 October 2026 at 08:00
Nature Biomedical Engineering, Published online: 06 October 2026; doi:10.1038/s41551-026-01786-5
A nanoscale metal–organic framework (MOF)-based cancer vaccine platform enables coordinated antigen presentation and innate immune activation, resulting in tumour regression, immune memory and protection against metastasis.